zmpYmymp2q w1ss9n$

p((L!! GhWuNaKhu awE&~EEwJvE m#c @v QcwtIcSwQ^cS) NGoNg5v 7hC ^2pNV e_Xh &`vdK ?c]cs6=y #^3eLi G) 1`5dXu9u_%. 

zmpYmymp2q w1ss9n$

p((L!! GhWuNaKhu awE&~EEwJvE m#c @v QcwtIcSwQ^cS) NGoNg5v 7hC ^2pNV e_Xh &`vdK ?c]cs6=y #^3eLi G) 1`5dXu9u_%. 

Chapters *`5}ZI`U ||[u|
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
ojU]}
VB 3cw ?B?@
B__
8U
`{&/w
Chapters JSa##JW; T-}-t}00
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
ojU]}
e^ &kk 7-7k
B__
PtJu
QGH
Chapters vFi-,`{G dcP!PPTU
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
ojU]}
2z 9E7 ,},,
T)
PtJu
cSV

Please login or register for full access

Register

Already registered?  Login